Source: iQoncept / Shutterstock
Deciphera Pharmaceuticals (NASDAQ:DCPH) recently unveiled its performance for the first quarter of 2024.
- Deciphera Pharmaceuticals exceeded expectations by reporting earnings per share of -52 cents, surpassing the analysts’ projected figure of -55 cents.
- The company recorded revenue amounting to $45.00 million.
- However, this fell short by 2.77% compared to the anticipated revenue of $46.28 million forecasted by analysts.
Article printed from InvestorPlace Media, https://investorplace.com/earning-results/2024/05/dcph-stock-earnings-deciphera-pharmaceuticals-for-q1-of-2024/.
©2024 InvestorPlace Media, LLC
